Background In March 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced
the seven-valent vaccine in the USA. We assessed the effect of PCV13 use on …

Background Growing evidence suggests respiratory syncytial virus (RSV) is an important
cause of respiratory disease in adults. However, the adult burden remains largely …

Background Influenza and respiratory syncytial virus (RSV) cause substantial mortality from
respiratory and other causes in the USA, especially among people aged 65 and older. …

Normative models of choice in economics and biology usually expect preferences to be
consistent across contexts, or “rational” in economic language. Following a large body of …

Background Estimates of influenza and respiratory syncytial virus (RSV) burden must be
periodically updated to inform public health strategies. We estimated seasonal influenza- and …

Research on the conditions favoring the evolution of complex cognition and its underlying
neural structures has increasingly stressed the role of environmental variability. These studies …

Background Influenza is rarely confirmed with laboratory testing and accurate assessment
of the overall burden of influenza is difficult. We used statistical modelling methods to …

Societal concern with the welfare of egg laying hens housed in conventional cages is
fostering a transition towards cage-free systems in many countries. However, although cage-free …

Objective The burden of respiratory syncytial virus (RSV) illness is not well characterised in
primary care. We estimated the burden of disease attributable to RSV in children in the UK …

When a new vaccine is introduced, it is critical to monitor trends in disease rates to ensure
that the vaccine is effective and to quantify its impact. However, estimates from observational …